Abingdon Health (LON:ABDX) Trading Down 3.2% – Here’s What Happened

Abingdon Health Plc (LON:ABDX)’s stock price dropped 3.2% during mid-day trading on Wednesday . The stock traded as low as GBX 7.20 ($0.09) and last traded at GBX 7.50 ($0.09). Approximately 34,747 shares were traded during trading, a decline of 84% from the average daily volume of 217,851 shares. The stock had previously closed at GBX 7.75 ($0.10).

Abingdon Health Trading Down 2.5 %

The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The firm has a market capitalization of £13.85 million, a price-to-earnings ratio of -899.00 and a beta of 0.13. The company has a 50-day moving average price of GBX 7.94 and a 200-day moving average price of GBX 9.42.

About Abingdon Health

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.